HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

W Volpi Selected Research

Scherilan

1/2005Clinical and immunohistochemical study of the effect of a cosmetic product in patients with asteatotic eczema.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


W Volpi Research Topics

Disease

5Chronic Urticaria
05/2010 - 10/2003
4Dermatomyositis (Dermatopolymyositis)
10/2014 - 10/2004
4Psoriasis (Pustulosis Palmaris et Plantaris)
07/2010 - 01/2001
4Erythema Multiforme
05/2008 - 02/2006
4Stevens-Johnson Syndrome (Lyell's Syndrome)
05/2008 - 02/2006
3Inflammation (Inflammations)
10/2014 - 10/2004
3Atopic Dermatitis (Atopic Eczema)
04/2011 - 11/2006
2Necrosis
10/2006 - 10/2004
1Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis)
01/2017
1Pyoderma Gangrenosum
01/2017
1Cutaneous Lupus Erythematosus
04/2016
1Vascular Skin Diseases
04/2015
1Vasculitis (Vasculitides)
04/2015
1Localized Scleroderma (Morphea)
10/2014
1Connective Tissue Diseases (Connective Tissue Disease)
10/2014
1Systemic Scleroderma (Systemic Sclerosis)
10/2014
1Urticaria (Hives)
07/2006
1Pruritus (Itching)
01/2005
1Eczema
01/2005
1Erythema
01/2001

Drug/Important Bio-Agent (IBA)

6CytokinesIBA
12/2010 - 10/2003
4Chemokine ReceptorsIBA
01/2017 - 10/2004
4InterleukinsIBA
01/2017 - 10/2004
4CD40 Ligand (CD40L)IBA
01/2017 - 10/2004
3Interleukin-5 (Interleukin 5)IBA
01/2017 - 10/2004
3Tacrolimus (Prograf)FDA LinkGeneric
04/2011 - 11/2006
3Ointments (Pastes)IBA
04/2011 - 01/2005
3AutoantibodiesIBA
05/2010 - 10/2003
2InterferonsIBA
01/2017 - 10/2006
2Interleukin-4 (Interleukin 4)IBA
01/2017 - 10/2004
2Interleukin-13IBA
01/2017 - 10/2004
2Pharmaceutical PreparationsIBA
04/2015 - 10/2014
2Etanercept (Enbrel)FDA Link
07/2010 - 03/2009
2AcitretinFDA Link
07/2010 - 03/2009
2Histamine Antagonists (Antihistamines)IBA
12/2006 - 01/2001
2CC ChemokinesIBA
10/2006 - 10/2004
2Monoclonal AntibodiesIBA
10/2006 - 10/2004
2CXC ChemokinesIBA
10/2006 - 10/2004
2Immunoglobulin E (IgE)IBA
07/2006 - 10/2003
2ChemokinesIBA
07/2006 - 10/2004
2IgE Receptors (Fc epsilon RI)IBA
07/2006 - 10/2003
2Alkaline PhosphataseIBA
10/2004 - 01/2001
2Tryptases (Tryptase)IBA
10/2004 - 01/2001
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2004 - 01/2001
1Interleukin-15 (Interleukin 15)IBA
01/2017
1Docetaxel (Taxotere)FDA Link
04/2016
1beta-cyclodextrin tetradecasulfate (CTDS)IBA
10/2014
1Toll-Like Receptors (Toll-Like Receptor)IBA
04/2011
1Granzymes (Granzyme)IBA
08/2010
1Fas Ligand Protein (Fas Ligand)IBA
08/2010
1Tretinoin (Retinoic Acid)FDA LinkGeneric
07/2010
1efalizumab (Raptiva)FDA Link
04/2009
1Interleukin-22 (IL-22)IBA
03/2009
1AntibodiesIBA
03/2009
1Interleukin-17 (Interleukin 17)IBA
03/2009
1Interleukin-23 (Interleukin 23)IBA
03/2009
1Matrix Metalloproteinases (MMPs)IBA
05/2008
1Hydrocortisone (Cortisol)FDA LinkGeneric
02/2007
1levocetirizineFDA LinkGeneric
12/2006
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
12/2006
1P-SelectinIBA
12/2006
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
12/2006
1hydrocortisone-17-butyrate (Locoid)FDA LinkGeneric
11/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2006
1Interleukin-13 Receptors (Interleukin 13 Receptor)IBA
10/2006
1CCR3 ReceptorsIBA
10/2006
1Interleukin-8 (Interleukin 8)IBA
07/2006
1ScherilanIBA
01/2005
1HLA-DR Antigens (HLA-DR)IBA
10/2004
1Peroxidase (Myeloperoxidase)IBA
10/2004
1Interferon-gamma (Interferon, gamma)IBA
10/2004
1Eosinophil Cationic ProteinIBA
10/2004
1Cetirizine (Zyrtec)FDA LinkGeneric
01/2001

Therapy/Procedure

2Therapeutics
04/2015 - 12/2006
2Aftercare (After-Treatment)
03/2009 - 01/2001
1Duration of Therapy
01/2005
1Intradermal Injections
10/2003